Ledger.Open graph →
SEC Form D · filed January 4, 2021

Redmile Biopharma Investments III, L.P

Offering
—
Sold
$500.2M
Exemption
Rule 506(b)
Industry
Pooled Investment Fund
Location
San Francisco, CA
Type
Pooled fund

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Mike Lee · San Francisco, CAExecAmrit Nagpal · San Francisco, CAExecJeremy Green · San Francisco, CAExecRedmile Group, Llc · San Francisco, CAExecScott B. Anchell · Newport News, VAExecMike Lee · San Francisco, CAExecJohn R. Lawson Ii · Newport News, VAExecRedmile Group, Llc · San Francisco, CAExecRedmile Biopharma Investments Iii (Gp), Llc · San Francisco, CAPromoterOliver R. Corbett · London, United KingdomExecRobert H. Orley · BLOOMFIELD HILLS, MIExecMichael Rosenberg · New York, NYExecRedmile Group, Llc · San Francisco, CAExecRedmile Biopharma Investments Iii (Gp), Llc · San Francisco, CAPromoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗